Wexford Capital’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-26,414
| Closed | -$161K | – | 273 |
|
|
2025
Q1 | $161K | Hold |
26,414
| – | – | 0.04% | 189 |
|
|
2024
Q4 | $167K | Hold |
26,414
| – | – | 0.03% | 172 |
|
|
2024
Q3 | $132K | Hold |
26,414
| – | – | 0.03% | 159 |
|
|
2024
Q2 | $161K | Hold |
26,414
| – | – | 0.04% | 179 |
|
|
2024
Q1 | $294K | Hold |
26,414
| – | – | 0.06% | 176 |
|
|
2023
Q4 | $296K | Hold |
26,414
| – | – | 0.06% | 131 |
|
|
2023
Q3 | $198K | Hold |
26,414
| – | – | 0.04% | 177 |
|
|
2023
Q2 | $233K | Buy |
+26,414
| New | +$233K | 0.05% | 165 |
|